MARISSA CROFUT: Open Payments
NPI 1952959546 · NORWALK, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 23 payments from 16 companies in 2025. Trend: 2023 $312 · 2024 $559 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $120 |
| Incyte Corporation | 3 | $60 |
| Rigel Pharmaceuticals, Inc. | 2 | $51 |
| Janssen Biotech, Inc. | 1 | $35 |
| JAZZ PHARMACEUTICALS INC. | 2 | $33 |
| Medtronic, Inc. | 1 | $33 |
| Kerecis Limited | 1 | $32 |
| Integra LifeSciences Corporation | 1 | $29 |
| Solventum Corporation | 1 | $28 |
| Smith+Nephew, Inc. | 1 | $23 |
Products named: JOURNAVX, TAVALISSE, MONJUVI, TECVAYLI, PTEYE PARATHYROID DETECTION SYSTEM, Kerecis SurgiClose, Integra, V.A.C.ULTA.
Industry payments across CT — which companies pay providers there.
